Cannabis - Articles - Page 3 | CARLAT PUBLISHING

CLINICAL UPDATE

Currently Available Cannabis Products

September 1, 2022

Alex K. Rahimi, MD. Addiction Psychiatrist, Fort Belvoir Community Hospital, VA. Assistant Professor of Psychiatry, Uniformed Services University, Bethesda, MD. Dr. Rahimi, author for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

The sale of medical and recreational cannabis products has become big business as the prevalence of cannabis use increases across the country. There has been an explosion in the number of available products and their potency. Here, we go over what sorts of products are on the market now and what the implications for our patients.

An Off-Label Guide to Gabapentin

January 31, 2022

Rajesh R. Tampi, MD, MS, DFAPA. and Chris Aiken, MD.

Rajesh R. Tampi, MD, MS, DFAPA. Professor of Medicine, Case Western Reserve University. Chairman, Department of Psychiatry & Behavioral Sciences, Cleveland Clinic Akron General, and Chief of Geriatric Psychiatry, Cleveland Clinic. Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. The authors have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Off-label gabapentin (Neurontin) got a bad rep when it missed the mark in bipolar disorder, but there may be something worth salvaging in this drug. Here, we weigh its pros and cons for anxiety, substance use disorders, sleep, pain, and hot flashes, and compare it to its underutilized cousin, pregabalin (Lyrica).

Nicotine Patch for Cannabis Withdrawal?

July 3, 2021

John O’Neal, MD.

John O’Neal, MD. Dr. O’Neal has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

As cannabis use becomes more widespread, treaters will inevitably see increases in patients reporting symptoms of cannabis withdrawal. Researchers in this study investigated whether a nicotine patch might help mitigate some of these symptoms. Results were not particularly promising, and should only be considered for patients who also use tobacco.

Cannabis and Kids

December 16, 2019

Child psychiatrists are grappling with the problem of pervasive use of marijuana in an age where legalization of use for adults has led to even greater use in teens. In this episode, Dr. Feder and Mara go over two recent interviews in The Carlat Child Psychiatry Report with Gabriella Gobbi, MD, PhD, of...

Outpatient Management of Opioid Addiction

October 3, 2019

Sandra Gomez-Luna, MD

Sandra Gomez-Luna, MD

Child, adolescent, and adult psychiatrist in Darien, CT. Medical Director of Parent Child Support Center, a subsidiary of Behavioral Health Care (BHcare)

Dr. Gomez-Luna has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

The opioid crisis demands that child psychiatrists understand more about outpatient treatment in adolescents as more of us are asked to participate in assessment and treatment planning for this population. In this QA, we discuss some of the well-laid-out approaches for child psychiatrists to manage opioid treatment within the child or teen’s community.

Assessing and Treating Cannabis Use Disorder

October 3, 2019

Gabriella Gobbi, MD, PhD

Gabriella Gobbi, MD, PhD

Professor, Department of Psychiatry, McGill University; Psychiatrist and Clinical Scientist at the McGill University Health Center

Dr. Gobbi has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Child psychiatrists are grappling with the problem of pervasive use of marijuana in an age where legalization of use for adults has led to even greater use in teens. In this QA, we discuss the impact of cannabis, its interaction with depression, and the conundrum of cannabis withdrawal so that child psychiatrists can gain tools for addressing marijuana use and addiction in their outpatient practice.

Motivational Interviewing With Teens About Weed

October 3, 2019

Elizabeth D’Amico, PhD

Elizabeth D’Amico, PhD

Senior Behavioral Scientist at RAND and member of the Motivational Interviewing Network of Trainers (MINT)

Dr. D’Amico has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Child psychiatrists can learn and use motivational interviewing to help teens across a range of substance use disorders. In this QA we cover the efficacy, training and implementation of outpatient motivational interviewing for marijuana and other substance use with teens.

N-acetylcysteine Not Effective for Cannabis Use Disorder in Adults

October 2, 2019

Brian Frankel, MD

Brian Frankel, MD Dr. Frankel has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

N-acetylcysteine (NAC), an over-the counter supplement related to the amino acid cysteine, has been shown to have some efficacy in adolescents with cannabis use disorder (CUD). This current study explores whether NAC can be effective for CUD in adult patients as well.

Is There a Case for Cannabis in the Treatment of Pain?

August 30, 2019

Adrienne Grzenda, MD, PhD.

Adrienne Grzenda, MD, PhD. Dr. Grzenda has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Many patients report that marijuana improves their pain. Their experience has a grain of truth to it, but not enough to classify cannabis as an analgesic.

Tips on Marijuana Use Disorder

March 20, 2019

Regardless of where you practice, you'll increasingly hear patients acknowledging regular marijuana (MJ) use, sometimes as a "medical treatment" for conditions ranging from back pain to ADHD. You might want to remind your patients that, whether legal or not, marijuana is still a drug with potential negative consequences. Here are...